Literature DB >> 24240672

Cure predictability during parathyroidectomy.

Robert Udelsman1, Patricia Donovan, Cary Shaw.   

Abstract

BACKGROUND: A mathematical model for primary hyperparathyroidism (1°HPTH) was developed and embedded in software to yield intraoperative predictability curves.
METHODS: A total of 1,754 consecutive 1°HPTH operative cases were screened to select 617 [554 single adenoma (SA), 63 multigland] patients with complete preoperative, intraoperative (pre-exploration, time 0, every 5 min post-resection), and postoperative parathyroid hormone (PTH) and calcium data. Data transformations and models were hypothesized and tested, including inverse functions, differences, half-lives, differences from projected half-lives, second-order kinetics, second-order derivatives, and time-dependent ratios. Sub-models of ratios were developed for time-dependent and initial-value combinations. For each time segment the log odds were modeled using multiple logistic stepwise regression. An idealized model was selected, embedded in software, and installed in a laptop computer to enable intraoperative decision analyses, PTH curve plotting, and storage and transmission of data. A subsequent cohort of 100 consecutive unselected patients [81 SAs, 19 multigland (13 hyperplasia, 2 MEN1, 1 lithium, 3 double adenomas)] inclusive of seven remedial cervical explorations were tested.
RESULTS: The model predicted an overall curative resection in 95 % of patients. In SA patients, cure was predicted in 78/81 patients with a mean probability of 99.3 % at 11.8 ± 10.4 min post-resection. In three cured patients, the software failed to suggest cure, because of a low baseline PTH or delayed clearance. The model also correctly predicted residual hyperfunctioning tissue in all tested multigland patients. All multigland patients underwent additional exploration with resection of residual disease resulting in a mean predicted cure rate of 97.9 % at 10.6 ± 7.3 min post-resection completion in 17 patients. In two patients, the software predicted a mean cure rate of 22 % due to either a low PTH baseline or delayed clearance. Overall, the software accurately predicted cure in 95 of 100 cured cases.
CONCLUSIONS: This intraoperative prediction software expedites termination of surgery with a high level of curative confidence. Alternatively, the model accurately predicts residual disease prompting additional exploration. Because the model is based on a large set of multivariate regression curves, PTH values obtained at any post-resection sampling interval generate prediction data with far greater accuracy than existing algorithms. The software is designed for convenient operative use and can print, store, and electronically transmit probability analyses and PTH curves in real-time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24240672     DOI: 10.1007/s00268-013-2327-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

Authors:  S K Libutti; H R Alexander; D L Bartlett; M L Sampson; M E Ruddel; M Skarulis; S J Marx; A M Spiegel; W Simmonds; A T Remaley
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

2.  The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.

Authors:  Robert Udelsman; Zhenqiu Lin; Patricia Donovan
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

3.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

4.  Streamlining of intra-operative parathyroid hormone measurements for cure during parathyroidectomy.

Authors:  Debra D Davis; May C Tee; Julianna Kowal; Daniel T Holmes; Sam M Wiseman
Journal:  Am J Surg       Date:  2013-05       Impact factor: 2.565

Review 5.  Contemporary and practical uses of intraoperative parathyroid hormone monitoring.

Authors:  Denise Carneiro-Pla
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

6.  Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?

Authors:  Denise M Carneiro; Carmen C Solorzano; Maria C Nader; Marcela Ramirez; George L Irvin
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

Review 7.  Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.

Authors:  Sherita H Golden; Karen A Robinson; Ian Saldanha; Blair Anton; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2009-06       Impact factor: 5.958

8.  Intra-operative parathyroid hormone kinetics and influencing factors with high baseline PTH: a prospective study.

Authors:  Dependra N Singh; Sushil K Gupta; Gyan Chand; Anjali Mishra; Gaurav Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra; Manoj Shukla; Amit Agarwal
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-01       Impact factor: 3.478

Review 9.  Clinical review: Parathyroid localization and implications for clinical management.

Authors:  John W Kunstman; Jonathan D Kirsch; Amit Mahajan; Robert Udelsman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

Review 10.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

View more
  10 in total

1.  What Should We Tell Our Patients? Lifetime Guarantee or is it 5- to 10-year Warranty on a Parathyroidectomy for Primary Hyperparathyroidism?

Authors:  Janice L Pasieka
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

2.  Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome.

Authors:  Francesco Tonelli; Carlo Biagini; Francesco Giudici; Federica Cioppi; Maria Luisa Brandi
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

3.  The CaPTHUS score as predictor of multiglandular primary hyperparathyroidism in a European population.

Authors:  M Mogollón-González; P Notario-Fernández; M Dominguez-Bastante; A Molina-Raya; M Serradilla-Martín; N Muñoz-Pérez; J I Arcelus-Martínez; J Villar-Del-Moral; J A Jiménez-Ríos
Journal:  Langenbecks Arch Surg       Date:  2016-04-14       Impact factor: 3.445

4.  Current predictive models do not accurately differentiate between single and multi gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units.

Authors:  O Edafe; E E Collins; C S Ubhi; S P Balasubramanian
Journal:  Ann R Coll Surg Engl       Date:  2017-09-15       Impact factor: 1.891

Review 5.  Point-of-care diagnostics for niche applications.

Authors:  Brian M Cummins; Frances S Ligler; Glenn M Walker
Journal:  Biotechnol Adv       Date:  2016-02-01       Impact factor: 14.227

6.  PRIMARY HYPERPARATHYROIDISM - STRATEGY FOR MULTIGLAND DISEASE IN THE ERA OF SPECT-CT.

Authors:  I T Cvasciuc; W Ismail; M Lansdown
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

7.  Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults.

Authors:  Hala Ahmadieh; Omar Kreidieh; Elie A Akl; Ghada El-Hajj Fuleihan
Journal:  Cochrane Database Syst Rev       Date:  2020-10-21

Review 8.  Sporadic multiple parathyroid gland disease--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Marcin Barczyński; Robert Bränström; Gianlorenzo Dionigi; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2015-11-05       Impact factor: 3.445

9.  Applicability of a shortened interpretation model for intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism in an endemic goiter region.

Authors:  Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Lindsay Brammen; Julian Heidtmann; Christian Scheuba
Journal:  Eur Surg       Date:  2018-07-11       Impact factor: 0.953

10.  Predictors of adenoma size and location in primary hyperparathyroidism.

Authors:  Barbara Filser; Verena Uslar; Dirk Weyhe; Navid Tabriz
Journal:  Langenbecks Arch Surg       Date:  2021-04-30       Impact factor: 3.445

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.